The White House has issued a new executive order changing the spacing of immunizations, breaking the existing Mumps, Measles, Rubella (MMR) vaccine into 3 separate vaccines, and continuing to push the “shared clinical-decision making” category. The order builds on a December 2025 presidential memorandum and a May 2026 executive order reaffirming its push to align US childhood vaccine recommendations with those of other other nations, while continuing to direct federal agencies to maximize parental choice over immunizations.1
The order states that the United States, "currently recommends more childhood vaccines than any peer nation, including more than twice as many vaccine doses as some European nations." The order notes that implementation of the administration's earlier directives had been "delayed due to litigation over the composition of the Advisory Committee on Immunization Practices."1
The order places immunizations into three tiers. Vaccines recommended for all children include measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Hib, pneumococcal disease, HPV, and varicella. A second tier, for high-risk groups, includes RSV monoclonal antibodies, hepatitis A and B, meningococcal B and ACWY, and dengue. And a third category, subject to "shared clinical decision-making" between parents and providers, covers hepatitis A and B, rotavirus, meningococcal disease, influenza, and COVID-19.1
Notably, the order calls for the combined MMR vaccine to eventually be replaced with "three separate single-disease shots once such products are domestically available," and directs that childhood immunizations be administered at separate visits "to the maximum extent feasible."1
The order also directs the Attorney General and the Departments of Justice, Education, and HHS to pursue legal action against state laws that conflict with parental authority, religious freedom, and exemption obligations tied to school vaccination requirements.1
The order states it creates no enforceable legal right and must be implemented "consistent with applicable law and subject to the availability of appropriations."1
Medical Professional Societies’ Reactions
As expected, reaction to the executive order was swift from medical societies.“There is no new evidence to justify significant changes to childhood immunization guidance,” American Academy of Pediatrics (AAP) President Andrew D. Racine, MD, PhD, FAAP, said in a statement. “Dozens of studies involving millions of people show there is no link between vaccines and autism, and yet federal leaders continue to promote this outdated, disproven idea to scare families. Today’s executive order will do nothing to support families of children with autism or advance understanding of the condition.”2
“In light of the August 10, 2026 Executive Order on childhood vaccine recommendations, the National Foundation for Infectious Diseases (NFID) strongly reiterates its endorsement of the American Academy of Pediatrics’ (AAP) childhood immunization schedule and reaffirms AAP’s evidence-based recommendations to protect children from vaccine-preventable diseases.
NFID shares the goal that unites parents, clinicians, and policymakers alike: keeping children healthy and protected from vaccine-preventable diseases. Reaching that goal depends on grounding vaccine recommendations in evidence. Any change to long-standing childhood vaccine recommendations should be supported by clear scientific evidence that schedule changes will better protect children and should follow rigorous, transparent review by independent experts. Changes made without that evidence risk weakening the protections children have today,” Robert Hopkins Jr, MD, medical director of the NFID, said in a statement to Contagion.
What You Need to Know
The executive order directs changes to the childhood vaccine schedule, including spacing immunizations across separate visits, limiting vaccines recommended universally, and eventually replacing the combined MMR vaccine with separate measles, mumps, and rubella shots.
Vaccines would be divided into three recommendation tiers, with some immunizations recommended for all children, others reserved for high-risk groups, and several—including influenza, COVID-19, rotavirus, and hepatitis A and B—subject to shared clinical decision-making.
Medical organizations strongly oppose the changes, with the AAP, NFID, and IDSA arguing that there is no new evidence supporting significant changes to childhood immunization guidance and warning that the order could undermine confidence in vaccine safety and effectiveness.
“This action follows an alarming pattern of government efforts to reduce Americans’ access to vaccines and sow unfounded doubt about vaccine safety and effectiveness. Infectious diseases physicians will continue to serve as an objective, reliable and evidence-based source of information for our patients and communities while advocating for vaccine policies grounded in sound science,” Ronald G. Nahass, MD, MHCM, FIDSA, president, Infectious Diseases Society of America (IDSA), said in a statement.3
Next Steps?
In terms of what happens next, Section 3 of the order gives HHS's Task Force on Safer Childhood Vaccines 90 days to present plans on offering single-antigen alternatives to combination vaccines, reassessing vaccine timing and sequencing, developing alternatives to aluminum adjuvants, and improving safety monitoring and transparency.
From a legal standpoint it is yet to be determined if there will be challenges to the executive order.
As this is an evolving story, look for more commentary from clinicians and former ACIP liaisons, and other interested stakeholders to learn more about what this executive order means in practice and the potential legality of it.
